Altria (MO) Price Target Raised to $64 by Barclays

On May 15, Barclays increased its price target on Altria Group, Inc. (MO) to $64 from $63 while maintaining an Underweight rating. The firm cited recent FDA guidance prompting potential innovations in the tobacco sector. During Q1 2026, CEO William Gifford reported a 7.3% increase in adjusted diluted EPS and noted shipment volumes for the on! portfolio grew nearly 18%, exceeding 46 million cans. These developments suggest that Altria’s strong cash flow could support shareholder returns through dividends and buybacks, highlighting ongoing growth opportunities in the market.